Alzheimer's disease (AD) is considered as a continuously pathological continuum. The AD pathophysiological process begins decades before the emergence of clinical symptoms. Recently, due to the advanced neuroimaging techniques and biochemical tests, various biomarkers are gradually identified, providing the ability to detect the evidence of AD pathology in the preclinical stage and further intervene the process of disease. Multimodal magnetic resonance imaging (MRI), with relatively non-invasive and economic benefits, is of great values to promote the clinical application. Therefore, researches involving brain structural and functional alterations in preclinical AD are summarized in this review.
Introduction
Alzheimer's disease (AD), characterized by progressive deficits in memory and other cognitive fields, has a long asymptomatic phase during which AD-related pathophysiological abnormalities, such as amyloid-β (Aβ) deposition, neurofibrillary tangles (NFTs) formation and proliferation of glial cells, have been apparent [1, 2] . Given lack of effective treatments and failure of numerous clinical trials at the stage of dementia, the preclinical phase of AD may provide a crucial opportunity for postponing and even preventing the process of the disease.
Due to the absence of specific clinical phenotypes and a lower sensitivity of the current neuropsychological scales in identifying potential individuals in presymptomatic AD, the application of pathological biomarkers stemmed from cerebrospinal fluid (CSF) and positron emission tomography (PET) is of great importance to achieve accurate diagnosis in vivo before the appearance of AD clinical symptoms. Reduced levels of Aβ42 combined with raised concentrations of tau in CSF and alternative Aβ and tau deposition in brain detected by PET imaging would provide relatively objective information reflecting AD-related pathology [3, 4] . However, the above-mentioned biomarkers have some defects in utility because of their invasiveness and radioactivity. Recently, the advances of multiple neuroimaging techniques, such as structural MRI (sMRI), functional MRI (fMRI), diffusion tensor imaging (DTI), have Review Yue Huang, Fang Liu emergence of neurodegeneration is sufficient to make a definite diagnosis of AD. In contrast, numerous studies have shown that Aβ load is not in parallels with brain anatomic changes and dysfunction. Moreover, several postmortem studies have confirmed that some individuals with the evidence of Aβ deposition may not display cognitive decline before their death. Therefore, the IWG-2 criteria have further highlighted the coexistence of decreased Aβ and increased total-tau or phosphorylated-tau in CSF for confirming AD pathology [2] .
Recently, the AD biomarker model has been gradually challenged [2, 12] . Some researchers consider that this model is just suitable for familial AD, while sporadic AD may not abide by the time sequence of various biomarkers [13] . In order to portray the preclinical phase accurately, Dubois et al. redefined the concept of preclinical AD on the basis of the risk dichotomy to progress to clinical AD [2] . Current studies have indicated that the combination of amyloid and tau pathology may be most suitable in stratifying individuals with the highest risk of conversion to AD [14] , while individuals exhibit an isolated brain amyloidopathy or tauopathy have relatively lower risk. Taken together, whatever the stage (preclinical, mild cognitive impairment or dementia), the co-occurrence of Aβ and tau could confirm the final diagnosis of AD.
Brain structural imaging

Structural MRI
Structural MRI, as a promising neuroimaging technique, has the potential to distinguish individuals with a high likelihood of conversion to AD, monitoring the disease progression and further evaluate the effectiveness of therapeutic intervention [15] . Brain structural abnormalities, characterized by local brain atrophy and disrupted global structural connectivity, have been previously shown in patients with AD. Using structural MRI, numerous studies have reported a significant volume reduction of the medial temporal region, parietal lobe, and posterior cingulate both in AD and MCI [15] [16] [17] . Current researches also validate the similarity of spatial distribution in structural changes occurring decades before the onset of AD symptoms [18] [19] [20] [21] . The earliest preclinical changes appear to be the entorhinal cortex approximately 8-10 years prior to the clinical symptom onset, followed by the hippocampus and amygdala, indicating that the medial temporal lobe is likely to be the offered a promising prospect that allows noninvasively investigating abnormalities of brain structure and spontaneous functional activities in early AD [5] . Additionally, previous studies have investigated that AD is a disconnection syndrome with multiple etiologies and complex mechanisms [6, 7] . Therefore, a systemlevel research based on brain anatomical and functional connectome is beneficial to gain an insight into the changes of whole-brain connectivities [8] . Here, we will introduce the conceptual framework of preclinical AD over the past decade. Then, we further elucidate specific neuroimaging properties in the presymptomatic stage of AD. 
Criteria for preclinical AD
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Neuroimaging Advances in Preclinical Alzheimer's disease earliest site attacked by Alzheimer's pathologies [22] [23] [24] . In support of this proposal, based on voxel-based morphometry (VBM) and shape analysis of MRI, Tondelli M et al. also confirmed the significant atrophy at baseline in the right medial temporal lobe for those individuals later diagnosed as AD [19] . It is inconsistent with findings in another study that local frontoparietal regions may be initially affected by emerging β-amyloid pathology while effects in the temporal cortex appear later [25] . These discrepancies of abnormal brain regions among different studies are partly explainable by different sample size and analysis strategies used. Additionally, brain structural changes may be affected by the interaction between amyloidosis and tauopathology. For instance, Fortea J et al.
proposed that cortical atrophy only occurs in subjects with both Aβ (+) and phosphorylatedtau (+) [26] . Cognitively healthy individuals only with the evidence of amyloidosis have reduced atrophy rates in cortical thickness while those with decreased CSF Aβ values and raised CSF tau levels simultaneously present accelerated atrophy in medial temporal structures, depicting a biphasic trajectory of brain structural changes in preclinical AD [27] .
Besides regional brain structural changes associated with worse cognitive performance in specific domains, discrete neuroanatomical networks have widespread interruption of information integration within and between brain regions. Currently, researchers have demonstrated the relationship between disruptions of gray matter network and ADrelated pathology in cognitively normal adults. Tijms, et al. found that lower Aβ42 levels in the CSF could be linearly associated with lower connectivity density at whole brain level, nonlinearly with lower clustering and higher path length values, indicating a reduced efficiency of network organization in preclinical AD [28] .
Diffusion tensor imaging
Diffusion MRI or DTI is another neuroimaging technique mirroring the white matter degradation [29] . Previous studies have manifested widespread white matter disruptions represented by decreased fractional anisotropy (FA), increased mean diffusivity (MD) and increased radial diffusivity (RD) in AD and MCI patients [30] [31] [32] . The existence of white matter microstructural changes has also been confirmed in the presymptomatic AD. Molinuevo et al. revealed that cognitively normal individuals with positive Aβ42 had increased axial diffusivity (A×D) in several white matter fiber tracts, such as corpus callosum, corona radiate, superior longitudinal fasciculus, etc., while other diffusion MRI indexes, including fractional anisotropy (FA), mean diffusivity (MD), and radial diffusivity (RD) have no differences [33] . This study demonstrated the subtle loss of axonal myelination with widely preserved white matter integrity in preclinical AD.
Converging evidences have shown that emerging amyloidosis alone is not sufficient to disrupt the brain structural connectivity, while individuals with the evidence of neurodegeneration are able to present alterations of the white matter connectome even without the amyloid pathology [34] . Furthermore, for individuals with both amyloid pathology and neurodegeneration (A+N+), abnormalities in structural network topology are more significant. Previous studies reported that MCI (A+N+) subjects exhibited distinct brain structural connectivity patterns which is in line with those alterations in patients with AD [35] . Similarly, employing DTI combined with graph theory, cognitively normal individuals with A+N+ showed obvious abnormalities in topological properties characterized by longer paths, lower efficiency, increased clustering and modularity compared with subjects only with neurodegenerative evidence [36] . We list changed brain structural patterns of preclinical AD in Table 1 .
Brain functional imaging
Functional MRI (fMRI), one of the most common imaging techniques, allows to reveal brain functional activities based on the principle of blood oxygenation level dependent (BOLD) [37] . Task-related fMRI can reflect the activation of local brain regions when subjects execute special tasks and accept external stimulus, whereas resting-state fMRI indirectly mirrors neural activity via exploring spontaneously lowfrequency amplitude at rest state. Accumulation of Aβ in the brain might bring about the synaptic dysfunction, leading to functional disconnection and abnormal information communication among multiple brain regions [38] . The progressive disruption in brain area connectivity contributes to subsequent cognitive decline, which is even prior to brain structural changes, such as neuronal apoptosis and atrophy [39, 40] .
Task-related functional MRI
Previous studies have investigated that patients
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Neuroimaging Advances in Preclinical Alzheimer's disease with MCI had increased functional activities within medial temporal lobe in compensating for brain structural damages [41] [42] [43] . One latest research has also verified the consistent functional activation in hippocampus during the memory encoding task for amyloid-positive asymptomatic subjects [44] . Longitudinally, raised hippocampus activity at baseline is likely to promote Aβ accumulation in brain cortices, followed by further cognitive decline, indicating the close correlation between hippocampus functional activation and AD-related pathology [45] . Furthermore, entorhinal cortex, one of the key components in default mode network (DMN), exhibits pathological aggregation of tau earlier than that in hippocampus and may present the earliest functional alterations [46] . Currently, it has been demonstrated that hippocampal activations and entorhinal deactivations are modulated during an episodic memory task. Nevertheless, amyloid-positive older adults with normal cognition have reduced ability to modulate activity in entorhinal cortex, but not hippocampus, signifying that entorhinal cortex may be the first brain area attacked by Aβ among the DMN regions [46] . This is consistent with findings mentioned earlier via structural MRI. In addition, normally, frontotemporal network connectivity is increased with aging during an incidental episodic encoding task in compensating for the reduced regional activity, further maintaining the performance of episodic memory. However, for subjects with Aβ deposition, they display no changes of functional connectivity in frontotemporal network, but increased regional activities, which is not associated with cognition improvement [47] . From the above observations, Aβ deposition will affect neuronal activity when memory encoding task is executed.
Besides DMN, frontoparietal control regions, associated with cognitive control or working memory, also have the Aβ accumulation even in the elderly [48, 49] . Oh et al. found hyperactivation in frontoparietal control regions during the process of working memory, suggesting that Aβ-related hyperactivation is not specific to the episodic memory system but occurs in frontoparietal control regions as well [48] . Furthermore, another study revealed that functional activity in frontoparietal control regions is related to the difficulty of tasks. For higher cognitive control load, Aβ-positive elderly showed reduced task-switching activation in the right inferior frontal cortex [49] .
Resting-state functional MRI
Patients with AD have shown functional disconnection within DMN regions, such as decreased functional connectivity between precuneus and left hippocampus [50] . Recently, cognitively normal elderly with Aβ load have presented the changed functional connectivity between regions within the DMN before the appearance of cognitive decline and behavioral symptoms. Sheline et al. have confirmed that those with brain amyloid deposition have significantly reduced functional connectivity linking precuneus to hippocampus, parahippocampus, anterior cingulate, etc., but increased functional connectivity with visual cortex, which is in line with the changed functional patterns of AD patients [51] . These consequences offer sufficient evidences that Aβ toxicity can be detected early via resting state fMRI. Another study has revealed that Aβ deposition is closely related to the decreased functional connectivity of perihinal cortex in the medial temporal lobe, but has no relationship with cognitive impairment and brain atrophy, indicating that abnormalities of functional connectivity within medial temporal lobe may be the earliest biomarker of preclinical AD before the occurrence of brain structural changes [52] . The mechanism that DMN is specifically targeted by Aβ may be the hyperactivation of DMN regions. The primary components of DMN, including medial prefrontal cortex, posterior cingulate, precuneus, inferior parietal lobe, etc., have higher functional connectivity with other brain regions. These key brain regions, also called hubs, play a crucial role in integrating the global brain information process and their consistent neural activities may intrigue or accelerate the accumulation of Aβ [53] [54] [55] . Additionally, functional disconnection within DMN regions are associated with the level of Aβ. Compared with subjects who deposit less Aβ in the brain, cognitively normal adults with more Aβ deposition have significantly decreased functional connectivity [39] . [57] . Increased global Aβ contributed to the raised functional connectivity between the anterior PFCN and DMN regions, but decreased relationship between anteriorventral SN and precuneus/DMN. Moreover, Aβ accumulation is also associated with the reduced network efficiency in the cerebrum-cerebellum system [58, 59] . Finally, functional activities for preclinical AD are summarized in Table 2 .
We also clarify the relationship among each neuroimaging modality in Figure 1 .
Future Directions
Recently, almost all of clinical trials involved in drugs targeting Aβ have ended up with failure. Due to the vast loss of neuron and widespread 
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Neuroimaging Advances in Preclinical Alzheimer's disease brain atrophy at the stage of dementia, therapeutic intervention focusing on patients with mild or moderate AD are less effective. Therefore, the proposition of term "preclinical AD" has a great potential to markedly prompt series of studies involving the secondary prevention of AD, further providing essential theoretical basis for achieving early diagnosis and preventing the process of AD. The long symptom-free phase of AD is also a crucial stage for fully understanding the brain information integration and the earliest neural alterations before cognitive decline. 
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